Table 2.
Prevalence estimate of CU in all Brazilian adults by age groups
Age (years) | Currently treated | Ever diagnosed | Ever experienced | ||||||
---|---|---|---|---|---|---|---|---|---|
% | 95% LCL | 95% UCL | % | 95% LCL | 95% UCL | % | 95% LCL | 95% UCL | |
18–24 | 0.17 | 0.09 | 0.25 | 0.27 | 0.16 | 0.37 | 0.32 | 0.21 | 0.43 |
25–34 | 0.18 | 0.12 | 0.24 | 0.43 | 0.28 | 0.57 | 0.59 | 0.43 | 0.75 |
35–44 | 0.31 | 0.12 | 0.51 | 0.53 | 0.32 | 0.74 | 0.64 | 0.42 | 0.87 |
45–54 | 0.31 | 0.08 | 0.55 | 0.61 | 0.35 | 0.88 | 0.74 | 0.46 | 1.02 |
55–64 | 0.12 | 0.04 | 0.21 | 0.32 | 0.15 | 0.48 | 0.53 | 0.28 | 0.77 |
65 and older | 0.03 | 0.00 | 0.06 | 0.10 | 0.00 | 0.25 | 0.11 | 0.00 | 0.25 |
LCL lower confidence limit, UCL upper confidence limit, CU chronic urticaria